University of Toronto

Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded (2020) Samaratunga H, Delahunt B, Egevad L, Srigley JR, Billis A, Bostwick DG, Camparo P, et al. Journal article Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant (2020) Aziz MD, Shah J, Kapoor U, Dimopoulos C, Anand S, Augustine A, Ayuk F, et al. Journal article Automated Deep-Learning-based Inversion Time Selection for Cardiac Late Gadolinium Enhancement Imaging (2020) Yoon SS, Schmidt M, Wintersperger BJ, Chitiboi T, Sharma P, Tillmanns C, Maier A, Wetzl J Conference contribution, Abstract of a poster Erratum to: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (Nature Communications, (2018), 9, 1, (3707), 10.1038/s41467-018-04989-w) (2019) Went M, Sud A, Foersti A, Halvarsson BM, Weinhold N, Kimber S, Van Duin M, et al. Journal article, Erratum Other Causes of Limbal Stem Cell Deficiency Reply (2019) Deng SX, Borderie V, Chan CC, Dana R, Figueiredo FC, Gomes JAP, Pellegrini G, et al. Journal article, Letter Aged hind-limb clasping experimental autoimmune encephalomyelitis models aspects of the neurodegenerative process seen in multiple sclerosis (2019) Cahill LS, Zhang MA, Ramaglia V, Whetstone H, Sabbagh MP, Yi TJ, Woo L, et al. Journal article Visualization of electrolyte flow in vanadium redox flow batteries using synchrotron X-ray radiography and tomography – Impact of electrolyte species and electrode compression (2019) Bevilacqua N, Eifert L, Banerjee R, Köble K, Faragó T, Zuber M, Bazylak A, Zeis R Journal article LUTATHERA (R) in first line therapy of G2 and G3 GEP-NETs (the NETTER-2 study) (2019) Ferone D, Pavel ME, Kunz P, De Herder W, Santoro P, Wegener A, Broberg P, et al. Conference contribution KEYNOTE-522: Phase III study of pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo (pbo) plus chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC) (2019) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur HL, Kuemmel S, Bergh J, et al. Conference contribution Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size (2019) Le Duc D, Giulivi C, Hiatt SM, Napoli E, Panoutsopoulos A, De Crescenzo A, Kotzaeridou U, et al. Conference contribution